Cyxone AB (publ) 4CX.F Stock
Cyxone AB (publ) Price Chart
Cyxone AB (publ) 4CX.F Financial and Trading Overview
Cyxone AB (publ) stock price | 0.0026 EUR |
Previous Close | 0.04 EUR |
Open | 0.03 EUR |
Bid | 0.04 EUR x 0 |
Ask | 0.06 EUR x 0 |
Day's Range | 0.03 - 0.03 EUR |
52 Week Range | 0.02 - 0.1 EUR |
Volume | 10K EUR |
Avg. Volume | 520 EUR |
Market Cap | 4.42M EUR |
Beta (5Y Monthly) | 0.573563 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
4CX.F Valuation Measures
Enterprise Value | 4.17M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.15405406 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Cyxone AB (publ) Stock Price History
Beta (5Y Monthly) | 0.573563 |
52-Week Change | -0.95% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.1 EUR |
52 Week Low | 0.02 EUR |
50-Day Moving Average | 0.05 EUR |
200-Day Moving Average | 0.04 EUR |
4CX.F Share Statistics
Avg. Volume (3 month) | 520 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 98.44M |
Float | 80.26M |
Short Ratio | N/A |
% Held by Insiders | 24.54% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -29.76% |
Return on Equity (ttm) | -55.91% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 6.4M EUR |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | -0.03 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | 3.27 EUR |
Current Ratio (mrq) | 4.273 |
Book Value Per Share (mrq) | 0.222 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Cyxone AB (publ)
Country | Germany |
State | N/A |
City | Malmö |
Address | Adelgatan 21 |
ZIP | 221 22 |
Phone | 46 7 08 88 21 72 |
Website | https://www.cyxone.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 7 |
Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.
Q&A For Cyxone AB (publ) Stock
What is a current 4CX.F stock price?
Cyxone AB (publ) 4CX.F stock price today per share is 0.0026 EUR.
How to purchase Cyxone AB (publ) stock?
You can buy 4CX.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cyxone AB (publ)?
The stock symbol or ticker of Cyxone AB (publ) is 4CX.F.
Which industry does the Cyxone AB (publ) company belong to?
The Cyxone AB (publ) industry is Biotechnology.
How many shares does Cyxone AB (publ) have in circulation?
The max supply of Cyxone AB (publ) shares is 685.38M.
What is Cyxone AB (publ) Price to Earnings Ratio (PE Ratio)?
Cyxone AB (publ) PE Ratio is now.
What was Cyxone AB (publ) earnings per share over the trailing 12 months (TTM)?
Cyxone AB (publ) EPS is -0.02 EUR over the trailing 12 months.
Which sector does the Cyxone AB (publ) company belong to?
The Cyxone AB (publ) sector is Healthcare.